Why fear FDI in pharma?

It would soon be time for the government to review its 2011 policy decision on foreign direct investment in the pharma sector. The occasion is ripe to consider perceptions on the impact of FDI on the industry.The FDI policy for the pharma sector was revised on November 8, 2011, essentially shifting the FDI(in relation to the brownfield investments) from the automatic to approval route. FDI in the sector is permitted up to 100 per cent.

Read Full Story>>